Rhinolight® - An Alternative to Allergic Rhinitis Therapy or Supportive Care? 

Authors

  • O. Wojas Department of the Environmental Hazards Prevention and Allergology Faculty of Health Sciences Medical University of Warsaw, Poland
  • B. Samolińsk Department of the Environmental Hazards Prevention and Allergology Faculty of Health Sciences Medical University of Warsaw, Poland
  • K. Furmańczyk Chair of Applied Mathematics, Faculty of Applied Informatics and Mathematics, Warsaw University of Life Sciences (SGGW), Poland
  • D. Dziewa-Dawidczyk Chair of Applied Mathematics, Faculty of Applied Informatics and Mathematics, Warsaw University of Life Sciences (SGGW), Poland
  • E. Krzych-Fałta Department of the Environmental Hazards Prevention and Allergology Faculty of Health Sciences Medical University of Warsaw, Poland

DOI:

https://doi.org/10.12970/2308-7978.2019.07.05

Keywords:

Allergic rhinitis, allergic rhinitis therapy, rhinolight.

Abstract

 Introduction: A review of the literature shows that intranasal phototherapy seems to be an important part of allergic rhinitis therapy. The main aim of this study was an attempt to evaluate the effectiveness of allergic rhinitis therapy based on UV radiation (UVA and UVB beams). The subjects in the study were 8 patients (5 women and 3 men) diagnosed with chronic allergic rhinitis. The research method was Rhinolight®, a device that emits a beam of visible light (85%): UVA: below 10% and UVB: below 3%. The effectiveness of the therapy was measured using a Peak Nasal Inspiratory Flow (PNIF) meter and evaluated on the basis of subjective complaints measured on a point scale. Results: An evaluation of subjective complaints using a point scale showed a statistically significant (p <0.05) improvement in nasal patency, reduced itching sensation and a smaller quantity of water discharge as a result of the phototherapy. An objective evaluation at the end of the therapy revealed significant improvement in nasal cavity patency compared to the situation before the phototherapy.

References


[1] Samoliński B, Arcimowicz M, Buczyłko K, Duda R, Emeryk A, Groblewska A, et al. Polskie Standardy Leczenia Nieżytów Nosa (PoSLeNN)
[Polish Rhinitis Treatment Standards] Stanowisko Panelu Ekspertów Polskiego Towarzystwa Alergologicznego
[The Position of a Panel of Experts of the Polish Society of Allergology], published by Medycyna Praktyczna. Kraków 2013; ISBN 978-83-7430-371-2.
[2] Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2 LEN and AllerGen). Allergy 2008; 63(suppl.86): 8-160.
[3] Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision. J Allergy Clin Immunol 2010; 126(3): 466-76. https://doi.org/10.1016/j.jaci.2010.06.047
[4] Samoliński B. Nieżyty nosa – klasyfikacja i postępowanie.
[w:] Otolaryngologia praktyczna
[Rhinitis: Classification and Management (in) Otolaryngologia praktyczna. Janczewski G., Via Medica 2005; 1: 274-293.
[5] Samoliński B, Sybilski AJ, Raciborski F, Tomaszewska A. Samel-Kowalik P. Walkiewicz A, et al. Prevalance of rhinitis In Polish population according to the ECAP Epidemiology of Allergic Disorders in Poland study. Otolaryngol Pol 2009; 63(4): 324-30. https://doi.org/10.1016/S0030-6657(09)70135-0
[6] Seidman MD, Gurgel RK, Lin SY, Schwartz SR, Baroody FM, Bonner JR, et al. Clinical practice guideline: Allergic rhinitis. Otolaryngol Head Neck Surg 2015; 152(1 Suppl): 1-43.
[7] Tatar EC, Korkmaz H, Surenoglu UA, et al. Effects of Rhinophototherapy on Quality of life in persistant allergic rhinitis. Clin Exp Otolarhingol 2013; 6(2): 73-77. https://doi.org/10.3342/ceo.2013.6.2.73
[8] Csoma Z, Ignacz F, Bor Z, et al. Intranasal irradiation with the xenon chloride ultrafiolet B laser improves allergic rhinitis. J Photochem Photobiol B 2004; 75(3): 137-144. https://doi.org/10.1016/j.jphotobiol.2004.05.001
[9] Csoma Z, Koreck A, Ignacz F, et al. PUVA treatment of the nasal cavity improves the clinocal symptoms of allergic rhinitis and inhibits the immediate-type hypersensensitivity reaction of the skin. J Photochem Photobiol B 2006; 83(1): 21-26. https://doi.org/10.1016/j.jphotobiol.2005.11.009
[10] Bella Z, Kiriksi A, Viharosne ED, et al. Rhinophototherapy in persistent allergic rhinitis. Eur Arch Otorhinolaryngol 2017; 274(3): 1543-1550. https://doi.org/10.1007/s00405-016-4358-x
[11] Cingi C, Cakli H, Songu M, Bal C. Phototherapy for allergic rhinitis: a prospective, randomized, single-blind, placebocontrolled study. Ther Adv Respir Dis 2010; 4(4): 209-213. https://doi.org/10.1177/1753465810374610
[12] Carson P, Lyons M. Severe rhinitis medicamentosa successfully treated with Rhinolight endonasal UV phototerapy. Ir Med J 2019; 112(2): 874

Downloads

Published

2019-03-25

Issue

Section

Articles